Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension. [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of a fixed-dose combination of olmesartan and indapamide versus the isolated dru…
-
FDA approval · 2022-03-21FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Eugia US LLC)
FDA approved the original application for esmolol hydrochloride in sodium chloride injection, a generic product manufactured by Eugia US LLC…
-
FDA approval · 2022-03-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original Abbreviated New Drug Application for verapamil hydrochloride from Heritage Pharmaceuticals (d/b/a Avet) as a gener…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension [Phase 3]
Phase 3 trial update evaluating long-term safety and tolerability of metoprolol versus nebivolol in hypertension.
-
FDA approval · 2022-03-15FDA Approved: NEBIVOLOL HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Nebivolol hydrochloride as an original generic application (ANDA) from Unichem Pharmaceuticals (USA), Inc. for hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-03-15FDA Approved: DOXAZOSIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for doxazosin (generic) by Rising Pharma Holdings, Inc., expanding access to this alpha-1 blocker for …
-
FDA approval · 2022-03-14FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic amlodipine/valsartan combination from Aurobindo Pharma Limited, expanding the avai…
-
FDA approval · 2022-03-11FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application to authorize Aurobindo Pharma Limited's generic fixed-dose combination tablet containing amlodipine,…
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: Local Heat Stress in Autonomic Failure Patients With Supine Hypertension [NA]
Clinical trial about local heat stress in autonomic failure patients with supine hypertension has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-03Clinical Trial Update: Controlling and Lowering Blood Pressure With The MOBIUSHD™ [NA]
A completed clinical trial update for MOBIUSHD™ addressing hypertension with posted results.
-
FDA approval · 2022-02-25FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for the generic combination Triamterene and Hydrochlorothiazide from BluePoint Laboratories. The…
-
FDA approval · 2022-02-25FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Triamterene and Hydrochlorothiazide from BluePoint Laboratories, enabling the marketing of t…
-
FDA approval · 2022-02-24FDA Approved: NORLIQVA — Original Application (CMP Pharma, Inc.)
FDA approved NORLIQVA (amlodipine) from CMP Pharma as an original application. The product is indicated for the treatment of hypertension an…
-
FDA approval · 2022-02-24FDA Approved: ENALAPRIL MALEATE ORAL SOLUTION — Original Application (NorthStar RxLLC)
FDA approved NorthStar RxLLC's enalapril maleate oral solution as an original ANDA, enabling a generic version of enalapril maleate.
-
FDA approval · 2022-02-24FDA Approved: CHLORTHALIDONE — Original Application (TAGI Pharma, Inc.)
FDA approved the original generic application for chlorthalidone by TAGI Pharma, Inc., allowing market authorization for this thiazide-like …
-
FDA approval · 2022-02-24FDA Approved: CHLORTHALIDONE — Original Application (TAGI Pharma, Inc.)
FDA approved the original application for chlorthalidone from TAGI Pharma, confirming marketing authorization for this generic diuretic.
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension [Phase 2]
Phase 2 trial update investigating the role of aldosterone in augmented exercise pressor reflex in hypertension has completed with posted re…
-
FDA approval · 2022-02-23FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Advagen Pharma Ltd)
Original approval of Triamterene and Hydrochlorothiazide (Advagen Pharma Ltd) under an ANDA.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: ARB, ACEi, DRi Effects on COVID-19 Course Disease
A completed clinical trial investigating the effects of ARB, ACEi, and DRi on the course of COVID-19 in patients with hypertension.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302) [Phase 3]
Phase 3 trial update evaluating antihypertensive efficacy and safety in Japanese patients with essential hypertension.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133) [Phase 3]
Phase 3 LIFE study update on losartan intervention for hypertension and left ventricular hypertrophy; completed trial.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Risk Reduction for Alzheimer's Disease [Phase 2, Phase 3]
Phase 2/3 clinical trial update on risk reduction for Alzheimer's disease in cognitively normal older adults, including those with hypertens…
-
FDA approval · 2022-02-14FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA granted supplemental approval for the combination drug valsartan and hydrochlorothiazide from Macleods Pharmaceuticals Limited.
-
FDA approval · 2022-02-09FDA Approved: CHLORTHALIDONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the generic chlorthalidone under an original ANDA from Rising Pharma Holdings, Inc.
-
FDA approval · 2022-02-07FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental ANDA for a generic fixed-dose combination of bisoprolol fumarate and hydrochlorothiazide manufactured by Mylan P…